Celiac disease: a clinical review

Abdominal Radiology

Volumn 42, Issue 2, 2017, Pages 351-360

  Al Bawardy, Badr ^a   Codipilly, D Chamil ^a   Rubio Tapia, Alberto ^a   Bruining, David H ^a   Hansel, Stephanie L ^a   Murray, Joseph A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Celiac disease; Enteropathy; Gluten free; imaging; Refractory; Sprue

Indexed keywords

ARTICLE; CELIAC DISEASE; DUODENUM BIOPSY; ENTEROPATHY ASSOCIATED T CELL LYMPHOMA; GASTROINTESTINAL DISEASE; GLUTEN FREE DIET; HUMAN; NONRESPONSIVE CELIAC DISEASE; PATHOGENESIS; PHYSICAL DISEASE BY BODY FUNCTION; PREVALENCE; PRIORITY JOURNAL; REFRACTORY CELIAC DISEASE; SEROLOGY; SMALL INTESTINE CARCINOMA; TREATMENT RESPONSE; ULCERATIVE JEJUNOILEITIS; BIOPSY; COMPLICATION; DIAGNOSTIC IMAGING; DIET THERAPY; DIFFERENTIAL DIAGNOSIS; PROGNOSIS;

BIOPSY; CELIAC DISEASE; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; DIET, GLUTEN-FREE; HUMANS; PROGNOSIS;

EID: 85009284703     PISSN: 2366004X     EISSN: 23660058     Source Type: Journal    
DOI: 10.1007/s00261-016-1034-y     Document Type: Article

References (145)

1. Fasano A, Berti I, Gerarduzzi T, et al. (2003) Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 163(3):286–292
2. Rubio-Tapia A, Ludvigsson JF, Brantner TL, Murray JA, Everhart JE (2012) The prevalence of celiac disease in the United States. Am J Gastroenterol 107(10):1538–1544 (quiz 1537). doi:10.1038/ajg.2012.219
3. Kim HS, Patel KG, Orosz E, et al. (2016) Time trends in the prevalence of celiac disease and gluten-free diet in the US population: results from the National Health and Nutrition Examination surveys 2009–2014. JAMA Intern Med 176(111):1716–1717
4. Choung RS, Ditah IC, Nadeau AM, et al. (2015) Trends and racial/ethnic disparities in gluten-sensitive problems in the United States: findings from the National Health and Nutrition Examination Surveys from 1988 to 2012. Am J Gastroenterol 110(3):455–461. doi:10.1038/ajg.2015.8
5. Tommasini A, Not T, Kiren V, et al. (2004) Mass screening for coeliac disease using antihuman transglutaminase antibody assay. Arch Dis Child 89(6):512–515
6. Catassi C, Fanciulli G, D’Appello AR, et al. (2000) Antiendomysium versus antigliadin antibodies in screening the general population for coeliac disease. Scand J Gastroenterol 35(7):732–736
7. Trevisiol C, Not T, Berti I, et al. (1999) Screening for coeliac disease in healthy blood donors at two immuno-transfusion centres in north-east Italy. Ital J Gastroenterol Hepatol 31(7):584–586
8. Volta U, Bellentani S, Bianchi FB, et al. (2001) High prevalence of celiac disease in Italian general population. Dig Dis Sci 46(7):1500–1505
9. West J, Logan RF, Hill PG, et al. (2003) Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut 52(7):960–965
10. Carlsson AK, Axelsson IE, Borulf SK, Bredberg AC, Ivarsson SA (2001) Serological screening for celiac disease in healthy 2.5-year-old children in Sweden. Pediatrics 107(1):42–45
11. Walker MM, Murray JA, Ronkainen J, et al. (2010) Detection of celiac disease and lymphocytic enteropathy by parallel serology and histopathology in a population-based study. Gastroenterology 139(1):112–119. doi:10.1053/j.gastro.2010.04.007
12. Kolho KL, Farkkila MA, Savilahti E (1998) Undiagnosed coeliac disease is common in Finnish adults. Scand J Gastroenterol 33(12):1280–1283
13. Mäki M, Mustalahti K, Kokkonen J, et al. (2003) Prevalence of celiac disease among children in Finland. N Engl J Med 348(25):2517–2524. doi:10.1056/NEJMoa021687
14. Csizmadia CGDS, Mearin ML, von Blomberg BME, Brand R, Verloove-Vanhorick SP (1999) An iceberg of childhood coeliac disease in the Netherlands. Lancet 353(9155):813–814. doi:10.1016/S0140-6736(99)00243-3
15. Catassi C, Ratsch IM, Gandolfi L, et al. (1999) Why is coeliac disease endemic in the people of the Sahara? Lancet (London, England) 354(9179):647–648
16. Barada K, Bitar A, Mokadem MA, Hashash JG, Green P (2010) Celiac disease in Middle Eastern and North African countries: a new burden? World J Gastroenterol 16(12):1449–1457
17. Rewers M (2005) Epidemiology of celiac disease: what are the prevalence, incidence, and progression of celiac disease? Gastroenterology 128(4 Suppl 1):S47–S51
18. Cummins AG, Roberts-Thomson IC (2009) Prevalence of celiac disease in the Asia-Pacific region. J Gastroenterol Hepatol 24(8):1347–1351. doi:10.1111/j.1440-1746.2009.05932.x
19. Abadie V, Sollid LM, Barreiro LB, Jabri B (2011) Integration of genetic and immunological insights into a model of celiac disease pathogenesis. Annu Rev Immunol 29:493–525
20. Tack GJ, Verbeek WH, Schreurs MW, Mulder CJ (2010) The spectrum of celiac disease: epidemiology, clinical aspects and treatment. Nat Rev Gastroenterol Hepatol 7(4):204–213. doi:10.1038/nrgastro.2010.23
21. Murray JA, Van Dyke C, Plevak MF, et al. (2003) Trends in the identification and clinical features of celiac disease in a North American community, 1950–2001. Clin Gastroenterol Hepatol 1(1):19–27. doi:10.1053/jcgh.2003.50004
22. Ludvigsson JF, Rubio-Tapia A, van Dyke CT, et al. (2013) Increasing incidence of celiac disease in a North American population. Am J Gastroenterol 108(5):818–824. doi:10.1038/ajg.2013.60
23. Riddle MS, Murray JA, Porter CK (2012) The incidence and risk of celiac disease in a healthy US adult population. Am J Gastroenterol 107(8):1248–1255. doi:10.1038/ajg.2012.130
24. Dixit R, Lebwohl B, Ludvigsson JF, et al. (2014) Celiac disease is diagnosed less frequently in young adult males. Dig Dis Sci 59(7):1509–1512. doi:10.1007/s10620-014-3025-6
25. Green PHR, Stavropoulos SN, Panagi SG, et al. (2001) Characteristics of adult celiac disease in the USA: results of a national survey. Am J Gastroenterol 96(1):126–131. doi:10.1111/j.1572-0241.2001.03462.x
26. Dogan Y, Yildirmaz S, Ozercan IH (2012) Prevalence of celiac disease among first-degree relatives of patients with celiac disease. J Pediatr Gastroenterol Nutr 55(2):205–208. doi:10.1097/MPG.0b013e318249378c
27. Ploski R, Ek J, Thorsby E, Sollid LM (1993) On the HLA-DQ(alpha 1*0501, beta 1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201. Tissue Antigens 41(4):173–177
28. Rubio-Tapia A, Van Dyke CT, Lahr BD, et al. (2008) Predictors of family risk for celiac disease: a population-based study. Clin Gastroenterol Hepatol 6(9):983–987. doi:10.1016/j.cgh.2008.04.008
29. Greco L, Romino R, Coto I, et al. (2002) The first large population based twin study of coeliac disease. Gut 50(5):624–628
30. Karell K, Louka AS, Moodie SJ, et al. (2003) HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum Immunol 64(4):469–477
31. Hadithi M, von Blomberg BM, Crusius JB, et al. (2007) Accuracy of serologic tests and HLA-DQ typing for diagnosing celiac disease. Ann Intern Med 147(5):294–302
32. Lebwohl B, Rubio-Tapia A, Assiri A, Newland C, Guandalini S (2012) Diagnosis of celiac disease. Gastrointest Endosc Clin N Am 22(4):661–677. doi:10.1016/j.giec.2012.07.004
33. Sollid LM, Thorsby E (1990) The primary association of celiac disease to a given HLA-DQ alpha/beta heterodimer explains the divergent HLA-DR associations observed in various Caucasian populations. Tissue Antigens 36(3):136–137
34. Trynka G, Zhernakova A, Romanos J, et al. (2009) Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. Gut 58(8):1078–1083. doi:10.1136/gut.2008.169052
35. Garner CP, Murray JA, Ding YC, et al. (2009) Replication of celiac disease UK genome-wide association study results in a US population. Hum Mol Genet 18(21):4219–4225. doi:10.1093/hmg/ddp364
36. Vriezinga SL, Auricchio R, Bravi E, et al. (2014) Randomized feeding intervention in infants at high risk for celiac disease. N Engl J Med 371(14):1304–1315
37. Lionetti E, Castellaneta S, Francavilla R, et al. (2014) Introduction of gluten, HLA status, and the risk of celiac disease in children. N Engl J Med 371(14):1295–1303
38. Andren Aronsson C, Lee HS, Koletzko S, et al. (2016) Effects of gluten intake on risk of celiac disease: a case–control study on a Swedish Birth cohort. Clin Gastroenterol Hepatol 14(3):403–409
39. Marild K, Stephansson O, Montgomery S, Murray JA, Ludvigsson JF (2012) Pregnancy outcome and risk of celiac disease in offspring: a nationwide case–control study. Gastroenterology 142(1):39–45
40. Marild K, Ye W, Lebwohl B, et al. (2013) Antibiotic exposure and the development of coeliac disease: a nationwide case–control study. BMC Gastroenterol 13(109):13–109
41. Ludvigsson JF, Nordenvall C, Jarvholm B (2014) Smoking, use of moist snuff and risk of celiac disease: a prospective study. BMC Gastroenterol 14(120):14–120
42. Patel AH, Loftus EV, Murray JA, et al. (2001) Cigarette smoking and celiac sprue: a case–control study. Am J Gastroenterol 96(8):2388–2391
43. Binder HJ (2015) Disorders of absorption. In: Kasper D, Fauci A, Hauser S, Longo D, Jameson JL, Loscalzo J (eds) Harrison’s principles of internal medicine, 19th edn. New York: McGraw-Hill Education
44. S G (1890) On the coeliac affection. St Bart Hosp Rep: 2417–2420
45. Rashid M, Cranney A, Zarkadas M, et al. (2005) Celiac disease: evaluation of the diagnosis and dietary compliance in Canadian children. Pediatrics 116(6):e754–e759. doi:10.1542/peds.2005-0904
46. Telega G, Bennet TR, Werlin S (2008) Emerging new clinical patterns in the presentation of celiac disease. Arch Pediatr Adolesc Med 162(2):164–168. doi:10.1001/archpediatrics.2007.38
47. Guandalini S, Assiri A (2014) Celiac disease: a review. JAMA Pediatr 168(3):272–278. doi:10.1001/jamapediatrics.2013.3858
48. Skowera A, Peakman M, Cleare A, et al. (2001) High prevalence of serum markers of coeliac disease in patients with chronic fatigue syndrome. J Clin Pathol 54(4):335–336
49. Sanders DS, Patel D, Stephenson TJ, et al. (2003) A primary care cross-sectional study of undiagnosed adult coeliac disease. Eur J Gastroenterol Hepatol 15(4):407–413
50. Halfdanarson TR, Litzow MR, Murray JA (2007) Hematologic manifestations of celiac disease. Blood 109(2):412–421. doi:10.1182/blood-2006-07-031104
51. Hanif FM, Luck NH, Abbas Z, et al. (2015) Early, non-refractory celiac disease associated with microscopic colitis and splenomegaly. J Coll Phys Surg-Pakistan 25(Suppl 1):S14–S16
52. Sadr-Azodi O, Sanders DS, Murray JA, Ludvigsson JF (2012) Patients with celiac disease have an increased risk for pancreatitis. Clin Gastroenterol Hepatol 10(10):1136–1142
53. Briggs JH, McKean D, Palmer JS, Bungay H (2014) Transient small bowel intussusception in adults: an overlooked feature of coeliac disease. BMJ Case Rep 20(10):2013–203156
54. Jakes AD, Bradley S, Donlevy L (2014) Dermatitis herpetiformis. BMJ 348:g2557. doi:10.1136/bmj.g2557
55. Collin P, Reunala T, Rasmussen M, et al. (1997) High incidence and prevalence of adult coeliac disease. Augmented diagnostic approach. Scand J Gastroenterol 32(11):1129–1133
56. Caproni M, Bonciolini V, D’Errico A, Antiga E, Fabbri P (2012) Celiac disease and dermatologic manifestations: many skin clue to unfold gluten-sensitive enteropathy. Gastroenterol Res Pract 2012:952753. doi:10.1155/2012/952753
57. Freeman HJ (2008) Neurological disorders in adult celiac disease. Can J Gastroenterol 22(11):909–911
58. Fisher AH, Lomasky SJ, Fisher MJ, Oppenheim YL (2008) Celiac disease and the endocrinologist: a diagnostic opportunity. Endocr Pract 14(3):381–388. doi:10.4158/ep.14.3.381
59. Ludvigsson JF, Sellgren C, Runeson B, Langstrom N, Lichtenstein P (2011) Increased suicide risk in coeliac disease—a Swedish nationwide cohort study. Dig Liver Dis 43(8):616–622. doi:10.1016/j.dld.2011.02.009
60. Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA (2013) ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol 108(5):656–676 (quiz 677). doi:10.1038/ajg.2013.79
61. Lewis NR, Scott BB (2010) Meta-analysis: deamidated gliadin peptide antibody and tissue transglutaminase antibody compared as screening tests for coeliac disease. Aliment Pharmacol Ther 31(1):73–81. doi:10.1111/j.1365-2036.2009.04110.x
62. Giersiepen K, Lelgemann M, Stuhldreher N, et al. (2012) Accuracy of diagnostic antibody tests for coeliac disease in children: summary of an evidence report. J Pediatr Gastroenterol Nutr 54(2):229–241. doi:10.1097/MPG.0b013e318216f2e5
63. Amarri S, Alvisi P, De Giorgio R, et al. (2013) Antibodies to deamidated gliadin peptides: an accurate predictor of coeliac disease in infancy. J Clin Immunol 33(5):1027–1030. doi:10.1007/s10875-013-9888-z
64. McGowan KE, Lyon ME, Butzner JD (2008) Celiac disease and IgA deficiency: complications of serological testing approaches encountered in the clinic. Clin Chem 54(7):1203–1209. doi:10.1373/clinchem.2008.103606
65. Lee SK, Green PH (2005) Endoscopy in celiac disease. Curr Opin Gastroenterol 21(5):589–594
66. Dickson BC, Streutker CJ, Chetty R (2006) Coeliac disease: an update for pathologists. J Clin Pathol 59(10):1008–1016. doi:10.1136/jcp.2005.035345
67. Oberhuber G (2000) Histopathology of celiac disease. Biomed Pharmacother 54(7):368–372. doi:10.1016/s0753-3322(01)80003-2
68. Corazza GR, Villanacci V, Zambelli C, et al. (2007) Comparison of the interobserver reproducibility with different histologic criteria used in celiac disease. Clin Gastroenterol Hepatol 5(7):838–843. doi:10.1016/j.cgh.2007.03.019
69. Husby S, Koletzko S, Korponay-Szabo IR, et al. (2012) European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 54(1):136–160. doi:10.1097/MPG.0b013e31821a23d0
70. Kurppa K, Salminiemi J, Ukkola A, et al. (2012) Utility of the new ESPGHAN criteria for the diagnosis of celiac disease in at-risk groups. J Pediatr Gastroenterol Nutr 54(3):387–391. doi:10.1097/MPG.0b013e3182407c6b
71. Klapp G, Masip E, Bolonio M, et al. (2013) Celiac disease: the new proposed ESPGHAN diagnostic criteria do work well in a selected population. J Pediatr Gastroenterol Nutr 56(3):251–256. doi:10.1097/MPG.0b013e318279887b
72. Mubarak A, Wolters VM, Gerritsen SA, et al. (2011) A biopsy is not always necessary to diagnose celiac disease. J Pediatr Gastroenterol Nutr 52(5):554–557. doi:10.1097/MPG.0b013e3181ef8e50
73. Barker CC, Mitton C, Jevon G, Mock T (2005) Can tissue transglutaminase antibody titers replace small-bowel biopsy to diagnose celiac disease in select pediatric populations? Pediatrics 115(5):1341–1346. doi:10.1542/peds.2004-1392
74. Alessio MG, Tonutti E, Brusca I, et al. (2012) Correlation between IgA tissue transglutaminase antibody ratio and histological finding in celiac disease. J Pediatr Gastroenterol Nutr 55(1):44–49. doi:10.1097/MPG.0b013e3182470249
75. Donaldson MR, Book LS, Leiferman KM, Zone JJ, Neuhausen SL (2008) Strongly positive tissue transglutaminase antibodies are associated with Marsh 3 histopathology in adult and pediatric celiac disease. J Clin Gastroenterol 42(3):256–260. doi:10.1097/MCG.0b013e31802e70b1
76. Trovato CM, Montuori M, Anania C, et al. (2015) Are ESPGHAN “biopsy-sparing” guidelines for celiac disease also suitable for asymptomatic patients? Am J Gastroenterol 110(10):1485–1489. doi:10.1038/ajg.2015.285
77. Saginur M, AlRefaee FAM, Spady DW, et al. (2013) Antitissue transglutaminase antibody determination versus upper endoscopic biopsy diagnosis of paediatric celiac disease. Paediatr Child Health 18(5):246–250
78. Wakim-Fleming J, Pagadala MR, Lemyre MS, et al. (2013) Diagnosis of celiac disease in adults based on serology test results, without small-bowel biopsy. Clin Gastroenterol Hepatol 11(5):511–516. doi:10.1016/j.cgh.2012.12.015
79. Salmi TT, Collin P, Reunala T, Maki M, Kaukinen K (2010) Diagnostic methods beyond conventional histology in coeliac disease diagnosis. Dig Liver Dis 42(1):28–32. doi:10.1016/j.dld.2009.04.004
80. Catassi C, Fasano A (2010) Celiac disease diagnosis: simple rules are better than complicated algorithms. Am J Med 123(8):691–693. doi:10.1016/j.amjmed.2010.02.019
81. Rubio-Tapia A, Rahim MW, See JA, et al. (2010) Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet. Am J Gastroenterol 105(6):1412–1420. doi:10.1038/ajg.2010.10
82. Megiorni F, Pizzuti A (2012) HLA-DQA1 and HLA-DQB1 in Celiac disease predisposition: practical implications of the HLA molecular typing. J Biomed Sci 19:88. doi:10.1186/1423-0127-19-88
83. Kaukinen K, Partanen J, Mäki M, Collin P (2002) HLA-DQ typing in the diagnosis of celiac disease. Am J Gastroenterol 97(3):695–699. doi:10.1016/S0002-9270(01)04033-3
84. Lauret E, Rodrigo L (2013) Celiac disease and autoimmune-associated conditions. BioMed Res Int 2013:127589. doi:10.1155/2013/127589
85. Poulain C, Johanet C, Delcroix C, Levy-Marchal C, Tubiana-Rufi N (2007) Prevalence and clinical features of celiac disease in 950 children with type 1 diabetes in France. Diabetes Metab 33(6):453–458. doi:10.1016/j.diabet.2007.06.004
86. Pham-Short A, Donaghue KC, Ambler G, et al. (2015) Screening for celiac disease in type 1 diabetes: a systematic review. Pediatrics 136(1):e170–e176
87. Hadithi M, de Boer H, Meijer JW, et al. (2007) Coeliac disease in Dutch patients with Hashimoto’s thyroiditis and vice versa. World J Gastroenterol 13(11):1715–1722
88. Sategna-Guidetti C, Volta U, Ciacci C, et al. (2001) Prevalence of thyroid disorders in untreated adult celiac disease patients and effect of gluten withdrawal: an Italian multicenter study. Am J Gastroenterol 96(3):751–757. doi:10.1111/j.1572-0241.2001.03617.x
89. Ansaldi N, Palmas T, Corrias A, et al. (2003) Autoimmune thyroid disease and celiac disease in children. J Pediatr Gastroenterol Nutr 37(1):63–66
90. Elfstrom P, Montgomery SM, Kampe O, Ekbom A, Ludvigsson JF (2008) Risk of thyroid disease in individuals with celiac disease. J Clin Endocrinol Metab 93(10):3915–3921. doi:10.1210/jc.2008-0798
91. Meloni A, Mandas C, Jores RD, Congia M (2009) Prevalence of autoimmune thyroiditis in children with celiac disease and effect of gluten withdrawal. J Pediatr 155(1):51–55, 55.e51. doi:10.1016/j.jpeds.2009.01.013
92. Kingham JG, Parker DR (1998) The association between primary biliary cirrhosis and coeliac disease: a study of relative prevalences. Gut 42(1):120–122
93. Floreani A, Betterle C, Baragiotta A, et al. (2002) Prevalence of coeliac disease in primary biliary cirrhosis and of antimitochondrial antibodies in adult coeliac disease patients in Italy. Dig Liver Dis 34(4):258–261
94. Ludvigsson JF, Elfstrom P, Broome U, Ekbom A, Montgomery SM (2007) Celiac disease and risk of liver disease: a general population-based study. Clin Gastroenterol Hepatol 5(1):63–69.e61. doi:10.1016/j.cgh.2006.09.034
95. Rubio-Tapia A, Herman ML, Ludvigsson JF, et al. (2012) Severe spruelike enteropathy associated with olmesartan. Mayo Clin Proc 87(8):732–738. doi:10.1016/j.mayocp.2012.06.003
96. DeGaetani M, Tennyson CA, Lebwohl B, et al. (2013) Villous atrophy and negative celiac serology: a diagnostic and therapeutic dilemma. Am J Gastroenterol 108(5):647–653. doi:10.1038/ajg.2013.45
97. Akobeng AK, Thomas AG (2008) Systematic review: tolerable amount of gluten for people with coeliac disease. Aliment Pharmacol Ther 27(11):1044–1052. doi:10.1111/j.1365-2036.2008.03669.x
98. Catassi C, Rossini M, Rätsch IM, et al. (1993) Dose dependent effects of protracted ingestion of small amounts of gliadin in coeliac disease children: a clinical and jejunal morphometric study. Gut 34(11):1515–1519
99. Catassi C, Fabiani E, Iacono G, et al. (2007) A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease. Am J Clin Nutr 85(1):160–166
100. Standard for Foods for Special Dietary Use for Persons Intolerant to Gluten. Codex Committee on Nutrition and Foods for Special Dietary Uses, vol Adopted in 1979. Amendment: 1983 and 2015. Revision: 2008.
101. Janatuinen EK, Kemppainen TA, Julkunen RJ, et al. (2002) No harm from five year ingestion of oats in coeliac disease. Gut 50(3):332–335
102. Sey MS, Parfitt J, Gregor J (2011) Prospective study of clinical and histological safety of pure and uncontaminated Canadian oats in the management of celiac disease. JPEN J Parenter Enteral Nutr 35(4):459–464. doi:10.1177/0148607110387800
103. Kemppainen TA, Heikkinen MT, Ristikankare MK, Kosma VM, Julkunen RJ (2010) Nutrient intakes during diets including unkilned and large amounts of oats in celiac disease. Eur J Clin Nutr 64(1):62–67. doi:10.1038/ejcn.2009.113
104. Thompson T, Dennis M, Higgins LA, Lee AR, Sharrett MK (2005) Gluten-free diet survey: are Americans with coeliac disease consuming recommended amounts of fibre, iron, calcium and grain foods? J Hum Nutr Diet 18(3):163–169. doi:10.1111/j.1365-277X.2005.00607.x
105. Pink IJ, Creamer B (1967) Response to a gluten-free diet of patients with the coeliac syndrome. Lancet 1(7485):300–304
106. Rashtak S, Murray JA (2012) Review article: celiac disease, new approaches to therapy. Aliment Pharmacol Ther 35(7):768–781. doi:10.1111/j.1365-2036.2012.05013.x
107. Leffler DA, Dennis M, Hyett B, et al. (2007) Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin Gastroenterol Hepatol 5(4):445–450
108. O’Mahony S, Howdle PD, Losowsky MS (1996) Review article: management of patients with non-responsive coeliac disease. Aliment Pharmacol Ther 10(5):671–680
109. Abdulkarim AS, Burgart LJ, See J, Murray JA (2002) Etiology of nonresponsive celiac disease: results of a systematic approach. Am J Gastroenterol 97(8):2016–2021
110. van Gils T, Nijeboer P, van Wanrooij RL, Bouma G, Mulder CJ (2015) Mechanisms and management of refractory coeliac disease. Nat Rev Gastroenterol Hepatol 12(10):572–579
111. Roshan B, Leffler DA, Jamma S, et al. (2011) The incidence and clinical spectrum of refractory celiac disease in a north american referral center. Am J Gastroenterol 106(5):923–928
112. Rubio-Tapia A, Murray JA (2010) Classification and management of refractory coeliac disease. Gut 59(4):547–557
113. Malamut G, Afchain P, Verkarre V, et al. (2009) Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology 136(1):81–90
114. Rubio-Tapia A, Kelly DG, Lahr BD, et al. (2009) Clinical staging and survival in refractory celiac disease: a single center experience. Gastroenterology 136(1):99–107
115. Al-Toma A, Verbeek WH, Hadithi M, von Blomberg BM, Mulder CJ (2007) Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. Gut 56(10):1373–1378
116. Delabie J, Holte H, Vose JM, et al. (2011) Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project. Blood 118(1):148–155
117. Sieniawski M, Angamuthu N, Boyd K, et al. (2010) Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation. Blood 115(18):3664–3670
118. Siegel RL, Miller KD, Jemal A (2016) Cancer statistics. CA Cancer J Clin 66(1):7–30
119. Askling J, Linet M, Gridley G, et al. (2002) Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology 123(5):1428–1435
120. Brousse N, Meijer JW (2005) Malignant complications of coeliac disease. Best Pract Res Clin Gastroenterol 19(3):401–412
121. Zar N, Holmberg L, Wilander E, Rastad J (1996) Survival in small intestinal adenocarcinoma. Eur J Cancer 12(9):2114–2119
122. Potter DD, Murray JA, Donohue JH, et al. (2004) The role of defective mismatch repair in small bowel adenocarcinoma in celiac disease. Cancer Res 64(19):7073–7077. doi:10.1158/0008-5472.can-04-1096
123. Castillo NE, Vanga RR, Theethira TG, et al. (2015) Prevalence of abnormal liver function tests in celiac disease and the effect of a gluten-free diet in the US population. Am J Gastroenterol 110(8):1216–1222. doi:10.1038/ajg.2015.192
124. Sainsbury A, Sanders DS, Ford AC (2011) Meta-analysis: coeliac disease and hypertransaminasaemia. Aliment Pharmacol Ther 34(1):33–40. doi:10.1111/j.1365-2036.2011.04685.x
125. Vajro P, Paolella G, Maggiore G, Giordano G (2013) Pediatric celiac disease, cryptogenic hypertransaminasemia, and autoimmune hepatitis. J Pediatr Gastroenterol Nutr 56(6):663–670. doi:10.1097/MPG.0b013e31828dc5c5
126. Pastore L, Carroccio A, Compilato D, et al. (2008) Oral manifestations of celiac disease. J Clin Gastroenterol 42(3):224–232. doi:10.1097/MCG.0b013e318074dd98
127. Ch’ng CL, Jones MK, Kingham JG (2007) Celiac disease and autoimmune thyroid disease. Clin Med Res 5(3):184–192. doi:10.3121/cmr.2007.738
128. Betterle C, Lazzarotto F, Spadaccino AC, et al. (2006) Celiac disease in North Italian patients with autoimmune Addison’s disease. Eur J Endocrinol 154(2):275–279. doi:10.1530/eje.1.02089
129. Iltanen S, Collin P, Korpela M, et al. (1999) Celiac disease and markers of celiac disease latency in patients with primary Sjogren’s syndrome. Am J Gastroenterol 94(4):1042–1046. doi:10.1111/j.1572-0241.1999.01011.x
130. Szodoray P, Barta Z, Lakos G, Szakall S, Zeher M (2004) Coeliac disease in Sjogren’s syndrome—a study of 111 Hungarian patients. Rheumatol Int 24(5):278–282. doi:10.1007/s00296-003-0360-x
131. Ludvigsson JF, Rubio-Tapia A, Chowdhary V, Murray JA, Simard JF (2012) Increased risk of systemic lupus erythematosus in 29,000 patients with biopsy-verified celiac disease. J Rheumatol 39(10):1964–1970. doi:10.3899/jrheum.120493
132. Hwang E, McBride R, Neugut AI, Green PH (2008) Sarcoidosis in patients with celiac disease. Dig Dis Sci 53(4):977–981. doi:10.1007/s10620-007-9974-2
133. Dahan S, Shor DB, Comaneshter D, et al. (2016) All disease begins in the gut: celiac disease co-existence with SLE. Autoimmun Rev 15(8):848–853. doi:10.1016/j.autrev.2016.06.003
134. Rutherford RM, Brutsche MH, Kearns M, et al. (2004) Prevalence of coeliac disease in patients with sarcoidosis. Eur J Gastroenterol Hepatol 16(9):911–915
135. Lerner A, Matthias T (2015) Rheumatoid arthritis-celiac disease relationship: joints get that gut feeling. Autoimmun Rev 14(11):1038–1047. doi:10.1016/j.autrev.2015.07.007
136. Sorensen HT, Thulstrup AM, Blomqvist P, et al. (1999) Risk of primary biliary liver cirrhosis in patients with coeliac disease: Danish and Swedish cohort data. Gut 44(5):736–738
137. Muratori P, Fabbri A, Lalanne C, Lenzi M, Muratori L (2015) Autoimmune liver disease and concomitant extrahepatic autoimmune disease. Eur J Gastroenterol Hepatol 27(10):1175–1179. doi:10.1097/meg.0000000000000424
138. van Gerven NM, Bakker SF, de Boer YS, et al. (2014) Seroprevalence of celiac disease in patients with autoimmune hepatitis. Eur J Gastroenterol Hepatol 26(10):1104–1107. doi:10.1097/meg.0000000000000172
139. Stewart M, Andrews CN, Urbanski S, Beck PL, Storr M (2011) The association of coeliac disease and microscopic colitis: a large population-based study. Aliment Pharmacol Ther 33(12):1340–1349. doi:10.1111/j.1365-2036.2011.04666.x
140. Kochhar R, Masoodi I, Dutta U, et al. (2009) Celiac disease and Budd Chiari syndrome: report of a case with review of literature. Eur J Gastroenterol Hepatol 21(9):1092–1094. doi:10.1097/MEG.0b013e328328f47f
141. Ludvigsson JF, West J, Card T, Appelros P (2012) Risk of stroke in 28,000 patients with celiac disease: a nationwide cohort study in Sweden. J Stroke Cerebrovasc Dis 21(8):860–867. doi:10.1016/j.jstrokecerebrovasdis.2011.05.008
142. Ciacci C, Tortora R, Scudiero O, et al. (2009) Early pregnancy loss in celiac women: the role of genetic markers of thrombophilia. Dig Liver Dis 41(10):717–720. doi:10.1016/j.dld.2009.02.050
143. Malamut G, Chandesris O, Verkarre V, et al. (2013) Enteropathy associated T cell lymphoma in celiac disease: a large retrospective study. Dig Liver Dis 45(5):377–384. doi:10.1016/j.dld.2012.12.001
144. Emilsson L, Lebwohl B, Sundstrom J, Ludvigsson JF (2015) Cardiovascular disease in patients with coeliac disease: a systematic review and meta-analysis. Dig Liver Dis 47(10):847–852. doi:10.1016/j.dld.2015.06.004
145. Emilsson L, Smith JG, West J, Melander O, Ludvigsson JF (2011) Increased risk of atrial fibrillation in patients with coeliac disease: a nationwide cohort study. Eur Heart J 32(19):2430–2437. doi:10.1093/eurheartj/ehr167